Extended release oral tablet formulation Ketamine Showing promise against treatment-resistant disease depression (TRD) Phase 2 proof-of-concept study results suggest. In this study, sustained-release ketamine administered twice...
ALBANY, N.Y. (NEXSTAR) — The New York State Department of Health (DOH) issued a public health alert on Friday, June 21, after officials confirmed that drug...
Recent Comments